SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-16-626856
Filing Date
2016-06-21
Accepted
2016-06-20 21:41:46
Documents
7
Period of Report
2016-06-20

Document Format Files

Seq Description Document Type Size
1 PREM14A d212696dprem14a.htm PREM14A 768697
2 GRAPHIC g212696g11y77.jpg GRAPHIC 26592
3 GRAPHIC g212696g16r08.jpg GRAPHIC 27424
4 GRAPHIC g212696g21j11.jpg GRAPHIC 24658
5 GRAPHIC g212696g50i50.jpg GRAPHIC 25468
6 GRAPHIC g212696g56z83.jpg GRAPHIC 16586
7 GRAPHIC g212696g57f70.jpg GRAPHIC 22487
  Complete submission text file 0001193125-16-626856.txt   967767
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-36296 | Film No.: 161723259
SIC: 2834 Pharmaceutical Preparations